Lilik Yusuf becomes Chairman of IAI; BPOM urges pharmacists to actively shape regulations

Lilik Yusuf Indrajaya has officially been elected as the new Chairman of the Central Board of the Indonesian Pharmacists Association (PP IAI) for the 2026-2030 term. Alongside the new leadership, the Indonesian Food and Drug Supervisory Agency (BPOM) stressed the critical role pharmacists play in the development of drug policies and regulations.

Head of BPOM, Taruna Ikrar, stated that pharmacists are strategically positioned to oversee rational drug use, educate the public, and monitor product safety post-market. He emphasized the necessity of collaboration between BPOM and IAI to strengthen pharmaceutical policies and regulations. "BPOM needs IAI's support in drafting policies and regulations," Taruna said.

“

BPOM needs IAI's support in drafting policies and regulations.

Ikrar further noted that advancements in health technology have broadened the scope of pharmacists' expertise. They now need to understand not only chemical-based drugs but also biological products and advanced therapy medicinal products. This evolution makes pharmacists a key strategic partner for BPOM in ensuring the safety, quality, and efficacy of medicines and health products available to the public.

He added that regulatory development offers a platform for collaboration between BPOM and pharmacists, grounded in scientific reasoning. "Every regulation can be discussed scientifically and should not be created to complicate matters, but rather to protect the public," Taruna stated. With Lilik Yusuf Indrajaya at the helm, the IAI is expected to be more proactive in contributing scientific insights to pharmaceutical policy formulation, aligning with the evolving landscape of health technology and the need for updated regulations.

“

Every regulation can be discussed scientifically and should not be created to complicate matters, but rather to protect the public.